Daan Gene Dirección

Dirección controles de criterios 2/4

Actualmente no disponemos de información suficiente sobre el CEO.

Información clave

Luo Huang

Chief Executive Officer (CEO)

CN¥1.3m

Compensación total

Porcentaje del salario del CEO	n/a
Permanencia del CEO	2.4yrs
Participación del CEO	n/a
Permanencia media de la dirección	sin datos
Promedio de permanencia en la Junta Directiva	2.5yrs

Actualizaciones recientes de la dirección

Recent updates

CEO

Luo Huang (44 yo)

2.4yrs

Permanencia

CN¥1,266,800

Compensación

Ms. Luo Huang is Non-Executive Director of Yunkang Group Limited from August 11, 2022. She serves as General Manager at Daan Gene Co., Ltd. She served as Deputy General Manager at Daan Gene Co., Ltd.since...

Miembros de la Junta

Nombre	Posición	Permanencia	Compensación	Propiedad
Luo Huang	GM & Director	2.4yrs	CN¥1.27m	sin datos
Bin Zhang	Deputy GM	5.6yrs	CN¥1.13m	sin datos
Zhengfu Zhu	Independent Director	2.5yrs	CN¥120.00k	sin datos
Li Qiang Huang	Supervisor	no data	sin datos	sin datos
Dianhan Wei	Vice Chairman Of the Board	3.8yrs	sin datos	sin datos
Wanyu Zhu	Chairman of the Supervisory Board	3.8yrs	sin datos	sin datos
Teng Hu	Supervisor	3.8yrs	sin datos	sin datos
Qian Long	Director	2.5yrs	sin datos	sin datos
Xiaoping Chen	Supervisor	2.5yrs	sin datos	sin datos
Yunhai Ji	Independent Director	2.5yrs	CN¥120.00k	sin datos

2.5yrs

Permanencia media

47.5yo

Promedio de edad

Junta con experiencia: La junta directiva de 002030 no se considera experimentada (2.5 años de permanencia promedio), lo que sugiere una nueva junta directiva.

Daan Gene Dirección

Dirección controles de criterios 2/4

Información clave

Actualizaciones recientes de la dirección

Daan Gene Co., Ltd., Annual General Meeting, Apr 19, 2024

Less than half of directors are independent

Insufficient new directors

Insufficient new directors

Daan Gene Co., Ltd., Annual General Meeting, Apr 20, 2022

Da an Gene Co., Ltd. of Sun Yat-Sen University Announces Executive Changes

Recent updates

Third quarter 2024 earnings released: CN¥0.076 loss per share (vs CN¥0.035 loss in 3Q 2023)

Daan Gene Co., Ltd. to Report Q3, 2024 Results on Oct 31, 2024

Second quarter 2024 earnings released: CN¥0.025 loss per share (vs CN¥0.27 profit in 2Q 2023)

New minor risk - Share price stability

Daan Gene Co., Ltd. to Report First Half, 2024 Results on Aug 31, 2024

Dividend reduced to CN¥0.015

Daan Gene Co., Ltd. Announces Final Dividend on A Shares for the Year 2023, Payable on 14 June 2024

First quarter 2024 earnings released: CN¥0.26 loss per share (vs CN¥0.026 profit in 1Q 2023)

Full year 2023 earnings released: EPS: CN¥0.075 (vs CN¥3.86 in FY 2022)

Daan Gene Co., Ltd., Annual General Meeting, Apr 19, 2024

Now 21% overvalued

Investor sentiment deteriorates as stock falls 15%

Now 20% overvalued

Daan Gene Co., Ltd. to Report Fiscal Year 2023 Results on Mar 30, 2024

Third quarter 2023 earnings released: CN¥0.035 loss per share (vs CN¥0.94 profit in 3Q 2022)

Daan Gene Co., Ltd. to Report Q3, 2023 Results on Oct 31, 2023

New major risk - Dividend sustainability

Second quarter 2023 earnings released: EPS: CN¥0.26 (vs CN¥1.36 in 2Q 2022)

Less than half of directors are independent

New minor risk - Share price stability

Investor sentiment deteriorates as stock falls 15%

Daan Gene Co., Ltd. Announces Final Dividend on A Shares for the Year 2022, Payable on June 13, 2023

Investor sentiment deteriorates as stock falls 18%

Full year 2022 earnings released: EPS: CN¥3.95 (vs CN¥2.58 in FY 2021)

Third quarter 2022 earnings released: EPS: CN¥0.94 (vs CN¥0.66 in 3Q 2021)

Second quarter 2022 earnings released: EPS: CN¥1.34 (vs CN¥0.33 in 2Q 2021)

Insufficient new directors

Upcoming dividend of CN¥1.11 per share

Daan Gene Co., Ltd. Proposes Final Cash Dividend on A Shares for the Year 2021, Payable on May 9, 2022

Insufficient new directors

Daan Gene Co., Ltd. Approves Final Dividend for the Year 2021

Daan Gene Co., Ltd., Annual General Meeting, Apr 20, 2022

Daan Gene Co., Ltd. Proposes Final Cash Dividend for 2021

Full year 2021 earnings released: EPS: CN¥2.58 (vs CN¥1.75 in FY 2020)

Full year 2021 earnings: EPS in line with expectations, revenues disappoint

Investor sentiment deteriorated over the past week

Da An Gene Co., Ltd. of Sun Yat-Sen University Announces Final Dividend Implementation Plan (A Shares) for 2020, Payable on 19 May 2021

First quarter 2021 earnings released: EPS CN¥1.29 (vs CN¥0.21 in 1Q 2020)

Full year 2020 earnings released: EPS CN¥2.77 (vs CN¥0.10 in FY 2019)

New 90-day low: CN¥29.03

Da an Gene Co., Ltd. of Sun Yat-Sen University Announces Executive Changes

Da An Gene Co., Ltd. of Sun Yat-Sen University to Report Fiscal Year 2020 Results on Mar 31, 2021

Investor sentiment deteriorated over the past week

New 90-day high: CN¥42.15

New 90-day low: CN¥31.98

First half earnings released

First half earnings released

Da An Gene Co., Ltd. of Sun Yat-Sen University to Report First Half, 2020 Results on Aug 29, 2020

New 90-day high - CN¥40.83

CEO

Permanencia

Compensación

Miembros de la Junta

Permanencia media

Promedio de edad